CAB-101

N/A

Report date: 2024/11/19 14:42:28

Base Information

Drug NameCAB-101
Drug Alias NameIP-9IP-10IP-13IP-14CAB-101 +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMidkine inhibitors
TargetsMidkine
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellmid
China Registration ClassN/A

Develop Information

Active CompaniesCellmid
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A